Oran, B., Thall, P., Alatrash, G., Im, J., Ramdial, J., Bassett, R., Popat, U., Kebriaei, P., Smallbone, P., Jewell, J., Champlin, R., Shpall, E. (2025). Phase II trial of venetoclax in combination with azacitidine as maintenance therapy for high-risk acute leukemia following allogeneic stem cell transplantation. Blood. https://doi.org/10.1182/blood-2025-2511